Lisa K. Brents - Concepedia

Author

Lisa K. Brents

University of Arkansas for Medical Sciences ORCID

Also Known As

L.K. Brents, Lisa Brents, Lisa K Brents, Lisa K. Brents

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

University of Arkansas for Medical Sciences Arkansas Department of Health Cayman Chemical (United States)Arkansas Children's Hospital University of Kansas

About

Lisa K. Brents is an author at University of Arkansas for Medical Sciences specializing in medicine, pharmacology, and cannabinoid pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	752
2	Health Sciences	3	3	132
3	Social Sciences	2	2	66
4	Natural Sciences	1	1	92
5	Public Health	1	1	96

Lisa K. Brents

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity Lisa K. Brents, Emily E. Reichard, Sarah M. Zimmerman, PLoS ONE	2011	210
Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton, Drug Metabolism and Disposition	2012	183
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity Lisa K. Brents, Anna Gallus‐Zawada, Anna Radomińska‐Pandya, Biochemical Pharmacology Cannabis UsePartial Agonist ActivityBiochemistryFunctional SelectivityMedicine	2012	142
AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies Kathryn A. Seely, Lisa K. Brents, Lirit N. Franks, Neuropharmacology Cannabis UseMolecular PharmacologyFunctional SelectivityAddictionDrug Discovery	2012	100
Marijuana, the Endocannabinoid System and the Female Reproductive System. Lisa K. Brents PubMed Chronic Marijuana UseHormonal ContraceptiveFertilityReproductive HealthGynecology	2016	96
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer Xinyi Liu, Indira Jutooru, Ping Lei, Molecular Cancer Therapeutics Breast OncologyCancer BiologyTumor BiologyTranscriptional RegulationSp Repressor Zbtb10	2012	92
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors Maheswari Rajasekaran, Lisa K. Brents, Lirit N. Franks, Toxicology and Applied Pharmacology Cannabis UseBiochemistryFunctional SelectivityMedicineSynthetic Cannabinoids Jwh-018	2013	90
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: Inhalation versus intraperitoneal injection Ramey Marshell, Tonisha Kearney-Ramos, Lisa K. Brents, Pharmacology Biochemistry and Behavior Cannabis UsePsychoactive DrugIntraperitoneal InjectionMedicinePhysiology	2014	89
A Major Glucuronidated Metabolite of JWH-018 Is a Neutral Antagonist at CB1 Receptors Kathryn A. Seely, Lisa K. Brents, Anna Radomińska‐Pandya, Chemical Research in Toxicology Metabolomic ProfilingPharmacotherapyExperimental PharmacologyCannabinoid Pharmacology018-Gluc Binds Cb1rs	2012	59
Differential Drug–Drug Interactions of the Synthetic Cannabinoids JWH-018 and JWH-073: Implications for Drug Abuse Liability and Pain Therapy Lisa K. Brents, Sarah M. Zimmerman, Amanda Saffell, Journal of Pharmacology and Experimental Therapeutics	2013	55

Page 1